Pathology of Perbutylated-N-Butyl-1-Deoxynojiromycin (An α-Glucosidase-1 Inhibitor) in Sprague-Dawley Rats

Toxicologic Pathology

Volumn 24, Issue 5, 1996, Pages 531-538

  Khan, Kanswar Nasir M ^a   Snook, Sandra S ^a   Semler, David E ^a   Baron, David A ^a   Alden, Carl L ^a  

^a PFIZER INC   (United States)

Author keywords

anti HIV compounds; cytoplasmic vacuolation; deoxynojiromycin (DNJ); HIV 1; toxicity

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIVIRUS AGENT; LIOTHYRONINE; MIGLUSTAT; NOJIRIMYCIN; SC 49483; THYROGLOBULIN; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ELECTRON MICROSCOPY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SALIVARY GLAND; STOMACH; TARGET ORGAN; THYROID GLAND; ULTRASTRUCTURE;

ALPHA-GLUCOSIDASES; ANIMALS; ANTIVIRAL AGENTS; BUTYRATES; FEMALE; MALE; PANCREAS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SALIVARY GLANDS; STOMACH; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029854668     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400501     Document Type: Article

References (31)

1. Block TM, Lu X., Platt FM, Foster GR, Gerlich WH, Blumberg BS, and Dwek RA (1994). Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. USA 91: 2235-2239.
2. Box GEP (1949). A general distribution theory for a class of likelihood criteria. Biometricka 36: 317-345.
3. Cotran RS, Kumar V., and Robbins SL (1994). Genetic disorders. In: Robbins Pathologic Basis of Disease, 5th ed., RS Cotran, V Kuma, and SL Robbins (eds). W. B. Saunders, Philadelphia, pp. 146–147.
4. Doms RW, Earl PL, Chakrabarti S., and Moss B. (1990). Human immunodeficiency virus types 1 and 2 and Simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J. Virol. 87: 648-652.
5. Fischel MA, Resnick L., Coombs R., Kremer AB, Pottage JC Jr, Fass RJ, Fife KH, Powderly WG, Collier AC, Aspinall RL, et al (1994). The safety and efficacy of combination N-butyl-deoxyojiromycin (SC-48334) and Zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3. J. Acq. Immune. Defic. Syn. 7: 139-147.
6. Fleet GWJ, Karpas A., Dwek RA, Fellows LE, Tyms AS, Petursson S., Namgoong SK, Ramsden NG, Smith PW, Son JC, Wilson F., Witty DR, Jacob GS, and Rademacher TW (1988). Inhibition of HIV replication by amino-sugar derivatives. FEBS Lett. 237: 128-133.
7. Fuhrmann U. and Ploegh H. (1985). Inhibitors of oligosaccharide processing. Biochem. Biophys. Acta 825: 95-110.
8. Glew RH, Basu A., Prence EM, and Remaley AT (1985). Lysosomal storage diseases. Lab. Invest. 53: 250-269.
9. Huxtable CR (1970). Ultrastructural changes by Swainsona galegifolia poisoning in the guinea pig. Aust. J. Exp. Biol. Sci. 48: 71-80.
10. Karlsson GB, Butters TD, Dwek RA, and Platt FM (1993). Effects of imino sugar N-butyldeoxynojirimycin on the glycosylation of recombinant gp120. J. Biol. Chem. 268: 570-576.
11. Karpas A., Fleet GWJ, Dwek RA, Petursson S., Namgoong SK, Ramsden NG, Jacob GS, and Rademacher TW (1988). Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc. Natl. Acad. Sci. USA 85: 9229-9233.
12. Lodish HF and Kong N. (1984). Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex. J. Cell Biol. 98: 1720-1729.
13. Lüllmann-Rauch R. (1982). Lysosomal glycogen storage mimicking the cytochemical picture of Pompe's disease as induced in rats by injection of an alpha-glucosidase inhibitor. II. Alterations in kidney, adrenal gland, spleen, and soleus muscle. Virchows Arch. [Cell Pathol.] 39: 187-202.
14. McKenzie RA, Reichmann KG, Dimmock CK, Dunster PJ, and Twist JO (1988). The toxicity of Castanospermum australe seeds for cattle. Aust. Vet. J. 65: 165-167.
15. Messer NT, Johnson PJ, Refsal KR, Nachreiner RF, Ganjam VK, and Krause GF (1994). Effect of food deprivation on baseline iodothyronine and cortisol concentrations in healthy, adult horses. Am. J. Vet. Res. 56: 116-121.
16. Myers MW (1990). New antiretroviral agents in the clinic. Rev. Infect. Dis. 12(5): 944-950.
17. Owens RJ and Compans RW (1990). The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology 179: 827-833.
18. Platt FM, Neises GR, Dwek RA, and Butters TD (1994). N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269: 8362-8365.
19. Ratner L. (1992). Glucosidase inhibitors for treatment of HIV-1 infection. AIDS Res. Hum. Retrovir. 8(2): 165-173.
20. Ratner L. and Vander Heyden N. (1993). Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs. AIDS Res. Hum. Retrovir. 9: 291-297.
21. Ratner L., Vander Heyden N., and Dedera D. (1991). Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity. Virology 181: 180-192.
22. Reichmann KG, Twist JO, and McKenzie RA (1989). Inhibition of alpha-glucosidase in cattle by Castanospermum australe: An attempted phenocopy of Pompe's disease. Aust. Vet. J. 66: 86-89.
23. Ruprecht RM, Bernard LD, Bronson R., Gama Sosa MA, and Mullaney S. (1991). Castanospermine vs. its 6-0-butanoyl analog: A comparison of toxicity and antiviral activity in vitro and in vivo. J. AIDS 4(1): 48-55.
24. Ruprecht RM, Mullaney S., Anderson J., and Bronson R. (1989). In vivo analysis of castanospermine, a candidate antiretroviral agent. J. AIDS 2: 149-157.
25. Rusconi S., Merrill DP, and Hirsch MS (1994). Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy. J. Infect. Dis. 170: 1361-1366.
26. Saul R., Ghidoni JJ, Molyneux RJ, and Elbein AD (1985). Castanospermine inhibits alpha-glucosidase activities and alters glycogen distribution in animals. Proc. Natl. Acad. Sci. USA 82: 93-97.
27. Schawaller M., Smith GE, Skehel JJ, and Wiley DC (1989). Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology 172: 367-369.
28. Stegelmeier BL, Molyneux RJ, Elbein AD, and James LF (1995). The lesions of locoweed (Astralagus mollissimus), swainsonine, and castanospermine in rats. Vet. Pathol. 32: 289-298.
29. Vail DM, Panciera DL, and Ogilvie GK (1995). Thyroid hormone concentrations in dogs with chronic weight loss, with special reference to cancer cachexia. J. Vet. Intern. Med. 8: 122-127.
30. Volker G., Andus T., Tran-Thi T., Schwartz RT, Decker K., and Heinrich PC (1983). 1-Deoxynojiromycin impairs oligosaccharide processing of alpha-1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes. J. Biol. Chem. 258: 12203-12209.
31. Weiner BJ (1971). Statistical Principles in Experimental Design, 2nd ed. McGraw-Hill, New York, pp. 149–185, 210-219.